| Name | Title | Contact Details |
|---|---|---|
Leonard Byrne |
Associate Vice President IT Engineering | Profile |
Blistex Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Oak Brook, IL. To find more information about Blistex Inc., please visit www.blistex.com
BPM+ Health™ is a community initiative to improve the quality and consistency of healthcare delivery. It will achieve this by applying business process modeling standards to clinical best practices, care pathways and workflows directly at the point of care. It is a cross-discipline group of professional organizations, clinical societies, and healthcare providers working together to develop and pilot standards-driven healthcare process automation techniques to fully realize the benefits of Healthcare IT. Founding Members: American College of Emergency Physicians (ACEP), Auxilium Technology Group, EvidenceCare, Mayo Clinic, MDIX, Perspecta, Red Hat, Trisotech, University of Utah, University of Washington, U.S. Department of Veterans Affairs Industry Supporters: HIMSS, HL7, HSPC, NCQA, AHRQ BPM+ Health is a program of the Object Management Group® (OMG®).
Find quality addiction treatment in North Carolina, where you’ll experience the care, flexibility, and support you need to conquer substance use.
CycleCast makes studio-quality indoor cycling more accessible than ever by delivering hit music and motivational instructors straight to your iPhone. CycleCast works with any indoor bike and brings the energy, intensity, and community of indoor cycling...
scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.